Ann: Botanix Announces Top Line BTX 1204 Atopic Dermatitis Data, page-211

I hope all BOT holders and their families are well and keeping safe. Nothing better than passing the time than watching your holdings increase in value. Especially in these sorts of uncertain times. So indeed some of the ' shorter term ' holders will no doubt also be pleased with this bounce. As I stated in my above post , there are some fantastic fundamentals in support of BOT as well as what was a ' unique and and ' exceptional market opportunity to have bought in on the recent dip. As a result of this rise over the last couple of sessions' , I have taken the opportunity to take half my investment off the table and will now see how it travels from here.

For me it is still about the ' unknown ' ' X ' factor on the bacterial killing side of their initiatives together with the strong ' cash ' position as the market in the Pharma space are looking for just about any glimpse of hope and resources, and I reckon you will ultimately see there is a strong connection between the transition of the Virus ( COVID-19 ) and the transitions to the advanced stages of the killer pneumonia - because at the end of the day pneumonia is pneumonia which in itself can ONLY be eradicated by an ' antibacterial ' or antibiotic. And it's needs to have a rapid efficacy ......

Best of success , enjoy , and most of all stay safe.